Chemoinformaics analysis of 1-hexylcyclohexa-1,3-diene
Molecular Weight | 164.292 | nRot | 5 |
Heavy Atom Molecular Weight | 144.132 | nRig | 6 |
Exact Molecular Weight | 164.156 | nRing | 1 |
Solubility: LogS | -4.265 | nHRing | 0 |
Solubility: LogP | 4.525 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 33.3759 |
nHD | 0 | BPOL | 20.0641 |
QED | 0.533 |
Synth | 2.545 |
Natural Product Likeliness | 1.634 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.745 |
Pgp-sub | 0.046 |
HIA | 0.003 |
CACO-2 | -4.596 |
MDCK | 0.0000139 |
BBB | 0.552 |
PPB | 0.9636 |
VDSS | 3.5 |
FU | 0.0319 |
CYP1A2-inh | 0.813 |
CYP1A2-sub | 0.826 |
CYP2c19-inh | 0.413 |
CYP2c19-sub | 0.871 |
CYP2c9-inh | 0.244 |
CYP2c9-sub | 0.856 |
CYP2d6-inh | 0.58 |
CYP2d6-sub | 0.874 |
CYP3a4-inh | 0.116 |
CYP3a4-sub | 0.277 |
CL | 0.808 |
T12 | 0.516 |
hERG | 0.196 |
Ames | 0.018 |
ROA | 0.061 |
SkinSen | 0.965 |
Carcinogencity | 0.691 |
EI | 0.978 |
Respiratory | 0.964 |
NR-Aromatase | 0.011 |
Antiviral | No |
Prediction | 0.723833 |